{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:43:59Z","timestamp":1788669839831,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00198-024-07314-y","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T06:42:25Z","timestamp":1734072145000},"page":"265-274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The effect of denosumab on minimum 3-years BMD changes in patients with osteoporotic hip fractures: a propensity score matching analysis"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9233-5358","authenticated-orcid":false,"given":"Chul-Ho","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1644-7862","authenticated-orcid":false,"given":"Keunho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3524-8706","authenticated-orcid":false,"given":"Ji Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"key":"7314_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/1759720X11424220","volume":"3","author":"PD Miller","year":"2011","unstructured":"Miller PD (2011) A review of the efficacy and safety of denosumab in postmenopausal women with osteoporosis. Ther Adv Musculoskelet Dis 3:271\u2013282. https:\/\/doi.org\/10.1177\/1759720X11424220","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"7314_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1302\/0301-620X.106B1.BJJ-2023-0740.R1","volume":"106-B","author":"E Harris","year":"2024","unstructured":"Harris E, Clement N, MacLullich A, Farrow L (2024) The impact of an ageing population on future increases in hip fracture burden. Bone Joint J 106-B:62\u201368. https:\/\/doi.org\/10.1302\/0301-620X.106B1.BJJ-2023-0740.R1","journal-title":"Bone Joint J"},{"key":"7314_CR3","doi-asserted-by":"publisher","first-page":"105548","DOI":"10.1016\/j.archger.2024.105548","volume":"127","author":"Y Choi","year":"2024","unstructured":"Choi Y, Han S, Kim YJ, Kim JW, Kim CH (2024) Hearing impairment increases the risk of hip fracture-related mortality and recurrent hip fractures: a propensity score matching analysis. Arch Gerontol Geriatr 127:105548. https:\/\/doi.org\/10.1016\/j.archger.2024.105548","journal-title":"Arch Gerontol Geriatr"},{"key":"7314_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.14740\/jocmr3287w","volume":"10","author":"S Batin","year":"2018","unstructured":"Batin S, Ozan F, Gurbuz K, Koyuncu S, Vatansever F, Uzun E (2018) Evaluation of risk factors for second hip fractures in elderly patients. J Clin Med Res 10:217\u2013220. https:\/\/doi.org\/10.14740\/jocmr3287w","journal-title":"J Clin Med Res"},{"key":"7314_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00223-011-9545-6","volume":"90","author":"H Hagino","year":"2012","unstructured":"Hagino H, Sawaguchi T, Endo N, Ito Y, Nakano T, Watanabe Y (2012) The risk of a second hip fracture in patients after their first hip fracture. Calcif Tissue Int 90:14\u201321. https:\/\/doi.org\/10.1007\/s00223-011-9545-6","journal-title":"Calcif Tissue Int"},{"key":"7314_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","volume":"26","author":"PM Camacho","year":"2020","unstructured":"Camacho PM, Petak SM, Binkley N et al (2020) American Association of Clinical Endocrinologists\/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract 26:1\u201346. https:\/\/doi.org\/10.4158\/GL-2020-0524SUPPL","journal-title":"Endocr Pract"},{"key":"7314_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.5005\/jp-journals-10080-1572","volume":"17","author":"A Bafor","year":"2022","unstructured":"Bafor A, Duncan ME, Iobst CA (2022) Early weight-bearing accelerates regenerate bone mineralisation: a pilot study comparing two post-operative weight-bearing protocols following intramedullary limb lengthening using the pixel value ratio. Strategies Trauma Limb Reconstr 17:148\u2013152. https:\/\/doi.org\/10.5005\/jp-journals-10080-1572","journal-title":"Strategies Trauma Limb Reconstr"},{"key":"7314_CR8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.amjmed.2024.02.012","volume":"137","author":"CW Goodman","year":"2024","unstructured":"Goodman CW (2024) Reconsidering the benefits of osteoporosis treatment: the case of bisphosphonates. Am J Med 137:476\u2013478. https:\/\/doi.org\/10.1016\/j.amjmed.2024.02.012","journal-title":"Am J Med"},{"key":"7314_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5371\/hp.2024.36.1.62","volume":"36","author":"JW Park","year":"2024","unstructured":"Park JW, Yoo JH, Lee YK, Park JS, Won YY (2024) Treatment of osteoporosis after hip fracture: survey of the Korean Hip Society. Hip Pelvis 36:62\u201369. https:\/\/doi.org\/10.5371\/hp.2024.36.1.62","journal-title":"Hip Pelvis"},{"key":"7314_CR10","doi-asserted-by":"publisher","first-page":"4840531","DOI":"10.1155\/2018\/4840531","volume":"2018","author":"MG Benedetti","year":"2018","unstructured":"Benedetti MG, Furlini G, Zati A, Letizia Mauro G (2018) The effectiveness of physical exercise on bone density in osteoporotic patients. Biomed Res Int 2018:4840531. https:\/\/doi.org\/10.1155\/2018\/4840531","journal-title":"Biomed Res Int"},{"key":"7314_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","volume":"5","author":"HG Bone","year":"2017","unstructured":"Bone HG, Wagman RB, Brandi ML et al (2017) 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diabetes Endocrinol 5:513\u2013523. https:\/\/doi.org\/10.1016\/S2213-8587(17)30138-9","journal-title":"Lancet Diabetes Endocrinol"},{"key":"7314_CR12","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.bone.2011.03.776","volume":"48","author":"F Johannesdottir","year":"2011","unstructured":"Johannesdottir F, Poole KE, Reeve J et al (2011) Distribution of cortical bone in the femoral neck and hip fracture: a prospective case-control analysis of 143 incident hip fractures; the AGES-REYKJAVIK Study. Bone 48:1268\u20131276. https:\/\/doi.org\/10.1016\/j.bone.2011.03.776","journal-title":"Bone"},{"key":"7314_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bone.2013.11.016","volume":"59","author":"RM Zebaze","year":"2014","unstructured":"Zebaze RM, Libanati C, Austin M et al (2014) Differing effects of denosumab and alendronate on cortical and trabecular bone. Bone 59:173\u2013179. https:\/\/doi.org\/10.1016\/j.bone.2013.11.016","journal-title":"Bone"},{"key":"7314_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40842-018-0062-7","volume":"4","author":"P Choksi","year":"2018","unstructured":"Choksi P, Jepsen KJ, Clines GA (2018) The challenges of diagnosing osteoporosis and the limitations of currently available tools. Clin Diabetes Endocrinol 4:12. https:\/\/doi.org\/10.1186\/s40842-018-0062-7","journal-title":"Clin Diabetes Endocrinol"},{"key":"7314_CR15","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1186\/s12891-022-05997-0","volume":"23","author":"L Jiang","year":"2022","unstructured":"Jiang L, Dong J, Wei J, Liu L (2022) Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis. BMC Musculoskelet Disord 23:1027. https:\/\/doi.org\/10.1186\/s12891-022-05997-0","journal-title":"BMC Musculoskelet Disord"},{"key":"7314_CR16","doi-asserted-by":"publisher","first-page":"115902","DOI":"10.1016\/j.bone.2021.115902","volume":"146","author":"CC Mok","year":"2021","unstructured":"Mok CC, Ho LY, Leung SMT, Cheung HN, Chen SPL, Ma KM (2021) Denosumab versus alendronate in long-term glucocorticoid users: a 12-month randomized controlled trial. Bone 146:115902. https:\/\/doi.org\/10.1016\/j.bone.2021.115902","journal-title":"Bone"},{"key":"7314_CR17","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1210\/jc.2018-02236","volume":"104","author":"H Lyu","year":"2019","unstructured":"Lyu H, Jundi B, Xu C, Tedeschi SK, Yoshida K, Zhao S, Nigwekar SU, Leder BZ, Solomon DH (2019) Comparison of denosumab and bisphosphonates in patients with osteoporosis: a meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 104:1753\u20131765. https:\/\/doi.org\/10.1210\/jc.2018-02236","journal-title":"J Clin Endocrinol Metab"},{"key":"7314_CR18","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1210\/jc.2019-00221","volume":"104","author":"R Eastell","year":"2019","unstructured":"Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D (2019) Pharmacological practice guideline. J Clin Endocrinol Metab 104:1595\u20131622. https:\/\/doi.org\/10.1210\/jc.2019-00221","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"7314_CR19","doi-asserted-by":"publisher","first-page":"105219","DOI":"10.1016\/j.jbspin.2021.105219","volume":"88","author":"K Ebina","year":"2021","unstructured":"Ebina K, Tsuboi H, Nagayama Y et al (2021) Effects of prior osteoporosis treatment on 12-month treatment response of romosozumab in patients with postmenopausal osteoporosis. Joint Bone Spine 88(5):105219","journal-title":"Joint Bone Spine"},{"key":"7314_CR20","doi-asserted-by":"publisher","first-page":"591","DOI":"10.20945\/2359-3997000000522","volume":"66","author":"BC Silva","year":"2022","unstructured":"Silva BC, Madeira M, d\u2019Alva CB, Maeda SS, de Holanda NCP, Ohe MN, Szejnfeld V, Zerbini CAF, de Paula FJA, Bandeira F (2022) Definition and management of very high fracture risk in women with postmenopausal osteoporosis: a position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Association of Bone Assessment and Metabolism (ABRASSO). Arch Endocrinol Metab 66:591\u2013603. https:\/\/doi.org\/10.20945\/2359-3997000000522","journal-title":"Arch Endocrinol Metab"},{"key":"7314_CR21","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s00198-024-07059-8","volume":"35","author":"M Chandran","year":"2024","unstructured":"Chandran M, Akesson KE, Javaid MK et al (2024) Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review. Osteoporos Int 35:1337\u20131358. https:\/\/doi.org\/10.1007\/s00198-024-07059-8","journal-title":"Osteoporos Int"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-024-07314-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-024-07314-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-024-07314-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T09:56:47Z","timestamp":1739440607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-024-07314-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["7314"],"URL":"https:\/\/doi.org\/10.1007\/s00198-024-07314-y","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]},"assertion":[{"value":"19 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}